Trials / Completed
CompletedNCT04612270
Quantification of Clinically Relevant Drug Induced Changes in HbO2 Affinity
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Medical University Innsbruck · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The presented study is an experimental in-vitro study without intervention in-vivo. The effects of nitric oxide and prostacyclins, 5-hydroxymethylfurfural and alpha-ketoglutarate, volatile anaesthetics on haemoglobin oxygen (HbO2) affinity will be investigated in-vitro. Venous blood samples of 20 healthy young volunteers (10 female, 10 male) will be collected twice in the period of one week. Informed consent will be given. Every blood collection will be accompanied by a venous blood gas analysis. The blood samples will be transferred to the laboratory for in-vitro recording of the complete oxygen dissociation curve (ODC). A newly developed in-vitro method will be used. On the first study day the blood samples will be exposed to three different concentrations of nitric oxide during the measurement, followed by two different vapourized prostacyclins. In addition, different concentrations of 5-hydroxymethylfurfural and alpha-ketoglutarate will be given to the blood samples for ODC recording. On the second study day the dose dependent effects of three different volatile anaesthetics will be investigated by exposing the blood samples to these drug while the measurements. Following these ODC recordings, aliquots of the blood samples will be frozen and investigated for storage related changes in HbO2 affinity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Venous blood collection | Two venous blood collections in within one week. No drug-related intervention in-vivo. |
Timeline
- Start date
- 2020-11-04
- Primary completion
- 2021-06-01
- Completion
- 2021-06-01
- First posted
- 2020-11-02
- Last updated
- 2021-09-08
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT04612270. Inclusion in this directory is not an endorsement.